| |
| |
|
| Insider
Information: |
Tyree James L |
| Relationship: |
Director |
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
286,780 |
|
|
Indirect Shares
|
1,199 |
|
|
| Direct
Value |
$14,978,033 |
|
|
|
Indirect Value
|
$124,708 |
|
|
| Total
Shares |
287,979 |
|
|
| Total
Value |
$15,102,741 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -70.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
Executive Vice President |
2009-02-27 |
132,176 |
2009-02-27 |
1,199 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2017-04-20 |
70,554 |
2014-06-02 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2015-05-22 |
0 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Director |
2019-05-08 |
80,590 |
2019-05-07 |
0 |
Premium* |
|
|
Genelux Corp |
GNLX |
Director |
2023-12-13 |
3,460 |
2023-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-05-14 |
4 |
OE |
$41.95 |
$575,277 |
D/D |
13,489 |
130,966 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2009-02-27 |
4 |
S |
$47.67 |
$498,458 |
D/D |
(10,454) |
132,176 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-07-09 |
4 |
OE |
$45.45 |
$694,185 |
D/D |
15,274 |
134,515 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2009-02-27 |
4 |
D |
$50.58 |
$344,602 |
D/D |
(6,813) |
142,630 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-29 |
4 |
D |
$54.22 |
$145,472 |
D/D |
(2,683) |
142,750 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-20 |
4 |
OE |
$41.03 |
$1,058,536 |
D/D |
25,798 |
142,858 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-19 |
4 |
S |
$56.08 |
$49,577 |
D/D |
(884) |
143,521 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-18 |
4 |
D |
$55.55 |
$37,996 |
D/D |
(684) |
144,405 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-17 |
4 |
D |
$55.55 |
$167,705 |
D/D |
(3,019) |
145,089 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-25 |
4 |
D |
$54.54 |
$592,086 |
D/D |
(10,856) |
145,433 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-15 |
4 |
A |
$55.56 |
$1,744,584 |
D/D |
31,400 |
148,108 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2009-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
45,800 |
149,443 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-06-01 |
4 |
OE |
$41.14 |
$1,641,811 |
D/D |
34,797 |
154,727 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-25 |
4 |
OE |
$42.50 |
$542,612 |
D/D |
12,768 |
156,289 |
0 |
- |
|
89 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
